Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01583868 · ClinicalTrials.gov registry record · NA
A Study to Evaluate the Product Feasibility of Two New Silicone Hydrogel Contact Lenses
A NA study, sponsored by Bausch & Lomb Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 216
- Enrollment target
NCT01583868: Completed NA study, sponsored by Bausch & Lomb Incorporated.
NCT01583868 is a NA study that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 216 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01583868, a NA study, has completed, sponsored by Bausch & Lomb Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 216 participants
- Enrollment target
Study Summary
The objective of this study is to determine the clinical feasibility and to evaluate the product performance of two RD2135-01 investigational soft contact lenses (Test 1 and Test 2) developed by Bausch + Lomb. The Test lenses will be compared to both Bausch + Lomb PureVision®2 HD (high definition) soft contact lenses and Ciba Vision Air Optix Aqua soft contact lenses when used among currently adapted soft contact lens wearers.
Primary Outcome
Visual acuity was assessed by distance high contrast logarithm of the minimum angle of resolution (logMAR).
Interventions
- DEVICE Air Optix Aqua
- DEVICE B&L RD2135-01 lens C
- DEVICE B&L RD2135-01 lens D
- DEVICE PureVision2
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 216 participants |
| Start Date | 2012-04 |
| Est. Completion | 2012-07 |
| Phase | NA |
What the finished NCT01583868 record still lists
NCT01583868 is an interventional study that assigns participants to a tested intervention. The registered 216 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).
The record links to 0 conditions, and to 4 interventions - of which Air Optix Aqua is the first listed.
NCT01583868 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01583868 about?
NCT01583868 is a clinical study titled "A Study to Evaluate the Product Feasibility of Two New Silicone Hydrogel Contact Lenses". The objective of this study is to determine the clinical feasibility and to evaluate the product performance of two RD2135-01 investigational soft contact lenses (Test 1 and Test 2) developed by Bausch + Lomb. The Test lenses will be compared to both Bausch + Lomb PureVision®2 HD (high definition) s...
What is the current status of trial NCT01583868?
This trial is currently completed. It is a NA study. The enrollment target is 216 participants. The study started on 2012-04. Estimated completion is 2012-07.
What interventions are being tested in trial NCT01583868?
The interventions under investigation include: Air Optix Aqua (DEVICE), B&L RD2135-01 lens C (DEVICE), B&L RD2135-01 lens D (DEVICE), PureVision2 (DEVICE).
Who is sponsoring clinical trial NCT01583868?
This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01583868's enrollment target sits among peer trials
216 485th of 2000 higher than 1,514 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02609685 · 216 participants · NA
Active Surveillance of Papillary Thyroid Microcarcinoma
- NCT04994873 · 216 participants · NA
Skills to Enhance Positivity in Suicidal Youth
- NCT05264779 · 216 participants · NA
The Periviable GOALS Decision Support Tool
- NCT05434130 · 216 participants · Phase 2
Modulating Exercise Dosage to Improve Concussion Recovery
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia